Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans.

Nagy CF, Leach TS, King A, Guttendorf R.

Clin Pharmacol Drug Dev. 2018 Aug;7(6):652-660. doi: 10.1002/cpdd.410. Epub 2017 Nov 10.

2.

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies.

Nagy CF, Leach TS, Hoffman JH, Czech A, Carpenter SE, Guttendorf R.

Clin Ther. 2016 Sep;38(9):2083-2097.e7. doi: 10.1016/j.clinthera.2016.07.170. Epub 2016 Aug 24.

Supplemental Content

Loading ...
Support Center